Literature DB >> 20454900

[NCL in animal models].

K Rüther1.   

Abstract

Neuronal ceroid lipofuscinoses (NCL) are severe neurodegenerative diseases leading to early death. They belong to the group of lysosomal storage diseases. Epileptic seizures, dementia and motor deficits are frequent symptoms which are to be found prior to a total dismantling of personality and death. At present 10 subtypes of NCL can be distinguished from which the genetic defect is known in eight. The encoded proteins are soluble or membrane proteins whose function is still unclear in most cases. The investigation of the pathology and pathophysiology of NCL is highly dependent on animal models. Mouse models existing for all forms with a known genetic defect play a prominent role. Unfortunately, the retinal phenotype of some mouse models is milder than in humans rendering the appreciation of a positive therapeutic effect more difficult. Because of the severity of NCL, therapy strategies only established in a mouse model will be transferred to humans very quickly.

Entities:  

Mesh:

Year:  2010        PMID: 20454900     DOI: 10.1007/s00347-009-2108-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  44 in total

1.  Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice.

Authors:  Masato Koike; Masahiro Shibata; Yoshiyuki Ohsawa; Hiroshi Nakanishi; Tomoyuki Koga; Satoshi Kametaka; Satoshi Waguri; Takashi Momoi; Eiki Kominami; Christoph Peters; Kurt von Figura; Paul Saftig; Yasuo Uchiyama
Journal:  Mol Cell Neurosci       Date:  2003-02       Impact factor: 4.314

2.  Neurophysiological findings in the northern epilepsy syndrome.

Authors:  A H Lang; A Hirvasniemi; J Siivola
Journal:  Acta Neurol Scand       Date:  1997-01       Impact factor: 3.209

3.  Cathepsin D deficiency is associated with a human neurodegenerative disorder.

Authors:  Robert Steinfeld; Konstanze Reinhardt; Kathrin Schreiber; Merle Hillebrand; Ralph Kraetzner; Wolfgang Bruck; Paul Saftig; Jutta Gartner
Journal:  Am J Hum Genet       Date:  2006-03-29       Impact factor: 11.025

4.  Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice.

Authors:  P Gupta; A A Soyombo; A Atashband; K E Wisniewski; J M Shelton; J A Richardson; R E Hammer; S L Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector.

Authors:  Dolan Sondhi; Neil R Hackett; Daniel A Peterson; Jamie Stratton; Michael Baad; Kelly M Travis; James M Wilson; Ronald G Crystal
Journal:  Mol Ther       Date:  2006-12-19       Impact factor: 11.454

6.  Activation of non-neuronal cells within the prenatal developing brain of sheep with neuronal ceroid lipofuscinosis.

Authors:  Graham W Kay; David N Palmer; Payam Rezaie; Jonathan D Cooper
Journal:  Brain Pathol       Date:  2006-04       Impact factor: 6.508

7.  A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis.

Authors:  Martin L Katz; Shahnawaz Khan; Tomoyuki Awano; S Adam Shahid; Aristotle N Siakotos; Gary S Johnson
Journal:  Biochem Biophys Res Commun       Date:  2005-02-11       Impact factor: 3.575

8.  Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons.

Authors:  Anu Jalanko; Jouni Vesa; Tuula Manninen; Carina von Schantz; Helena Minye; Anna-Liisa Fabritius; Tarja Salonen; Juhani Rapola; Massimiliano Gentile; Outi Kopra; Leena Peltonen
Journal:  Neurobiol Dis       Date:  2005-02       Impact factor: 5.996

9.  Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis.

Authors:  Sanna Partanen; Aleksi Haapanen; Catherine Kielar; Charles Pontikis; Noreen Alexander; Teija Inkinen; Paul Saftig; Thomas H Gillingwater; Jonathan D Cooper; Jaana Tyynelä
Journal:  J Neuropathol Exp Neurol       Date:  2008-01       Impact factor: 3.685

10.  A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis.

Authors:  Tomoyuki Awano; Martin L Katz; Dennis P O'Brien; Istvan Sohar; Peter Lobel; Joan R Coates; Shahnawaz Khan; Gayle C Johnson; Urs Giger; Gary S Johnson
Journal:  Mol Genet Metab       Date:  2006-04-18       Impact factor: 4.204

View more
  1 in total

1.  A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.

Authors:  Natalie A Villani; Garrett Bullock; Jennifer R Michaels; Osamu Yamato; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Gary S Johnson; Martin L Katz
Journal:  Mol Genet Metab       Date:  2019-04-17       Impact factor: 4.797

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.